Loading...
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
Core-binding factor (CBF) acute myeloid leukemia (AML) encompasses AML with inv(16)(p13.1q22) and AML with t(8;21)(q22;q22.1). Despite sharing a common pathogenic mechanism involving rearrangements of the CBF transcriptional complex, there is growing evidence for considerable genotypic heterogeneity...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757000/ https://ncbi.nlm.nih.gov/pubmed/33351131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002673 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|